So why didn't they publish the data pertaining to the trial? As far as I'm concerned clinical significance is just as important as statistical significance with this and the only data made available was to do with regaining smell function.
Hopefully we'll see it in the quarterly
- Forums
- ASX - By Stock
- Ann: Viraleze shows antiviral efficacy in COVID-19 patients
So why didn't they publish the data pertaining to the...
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.23M |
Open | High | Low | Value | Volume |
9.8¢ | 10.5¢ | 9.8¢ | $24.59K | 236.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 72989 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 29081 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 72989 | 0.100 |
1 | 14543 | 0.099 |
3 | 84000 | 0.098 |
1 | 6185 | 0.097 |
4 | 185417 | 0.096 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 29081 | 3 |
0.110 | 121708 | 8 |
0.115 | 118531 | 6 |
0.120 | 89055 | 5 |
0.125 | 286400 | 4 |
Last trade - 10.49am 15/07/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |